Literature DB >> 4320008

The Coronary Drug Project. Initial findings leading to modifications of its research protocol.

.   

Abstract

Mesh:

Substances:

Year:  1970        PMID: 4320008

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  32 in total

Review 1.  Postmenopausal hormone therapy, SERMs, and coronary heart disease in women.

Authors:  N K Wenger; D Grady
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.

Authors:  E Oger; P Y Scarabin
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 3.  Hormone replacement therapy: a time for pause.

Authors:  Salim Yusuf; Sonia Anand
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

4.  Cardiovascular effects of testosterone: implications of the "male menopause"?

Authors:  K S Channer; T H Jones
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

5.  Effects of estrogens and progestins on high density lipoproteins.

Authors:  R M Krauss; F T Lindgren; J Wingerd; D D Bradley; S Ramcharan
Journal:  Lipids       Date:  1979-01       Impact factor: 1.880

6.  Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.

Authors:  James J Schlesselman
Journal:  J R Soc Med       Date:  2016-01       Impact factor: 5.344

Review 7.  Niacin for primary and secondary prevention of cardiovascular events.

Authors:  Stefan Schandelmaier; Matthias Briel; Ramon Saccilotto; Kelechi K Olu; Armon Arpagaus; Lars G Hemkens; Alain J Nordmann
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

Review 8.  Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins.

Authors:  M Seed
Journal:  Drugs       Date:  1994       Impact factor: 9.546

9.  Ethical issues and clinical trials.

Authors:  D S Shimm; R G Spece
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials.

Authors:  Eleanor J Murray; Miguel A Hernán
Journal:  Clin Trials       Date:  2016-03-07       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.